S&P 500 Futures
(0.02%) 5 518.25 points
Dow Jones Futures
(0.13%) 39 897 points
Nasdaq Futures
(0.06%) 19 762 points
Oil
(-0.02%) $81.61
Gas
(0.50%) $2.83
Gold
(-0.24%) $2 338.80
Silver
(0.14%) $29.57
Platinum
(0.59%) $1 007.70
USD/EUR
(0.12%) $0.933
USD/NOK
(-0.05%) $10.53
USD/GBP
(0.02%) $0.788
USD/RUB
(-0.85%) $87.25

Aktualne aktualizacje dla Verastem Inc [VSTM]

Giełda: NASDAQ Sektor: Healthcare Branża: Biotechnology
Ostatnio aktualizowano24 birž. 2024 @ 23:00

-1.90% $ 3.10

Live Chart Being Loaded With Signals

Commentary (24 birž. 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 0.05% compare to its pairs and should correct upwards.

Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK...

Stats
Dzisiejszy wolumen 351 793
Średni wolumen 686 198
Kapitalizacja rynkowa 78.51M
EPS $-1.260 ( Q1 | 2024-05-09 )
Następna data zysków ( $-1.030 ) 2024-08-06
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.720
(Sector) 42.63
(Industry) 24.32
ATR14 $0.00800 (0.26%)
AADI 3.55%
ABCL -3.79%
ABCM 0.04%
ABEO -5.02%
ABIO -0.29%
ABOS -3.03%
ABSI 0.66%
ABUS 0.66%
ABVX 2.61%
ACAD 3.79%
ACER -17.95%
ACET 9.49%
ACGN 1.29%
ACHL 0.22%
ACHV -4.83%
ACIU 2.47%
ACLX -0.09%
ACRV -5.30%
ACST -0.31%
ACXP -2.15%
ADAG 0.69%
ADAP -1.06%
ADGI 0.87%
ADIL 2.68%
ADMA 0.09%
ADPT 1.54%
ADTX -2.08%
ADVM 1.63%
ADXN -5.75%
AEON -7.34%
AEZS -1.10%
AFMD 1.02%
AGEN 4.60%
AGIO 0.02%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -0.69%
AKRO 2.80%
AKTX -1.08%
AKUS 0.00%
ALBO 0.00%
ALDX -5.46%
ALEC 0.44%
ALGS -4.88%
ALKS -1.28%
ALLK 8.11%
ALLO 2.35%
ALLR -28.40%
ALNA 3.16%
ALNY 34.52%
ALPN 0.02%
ALPX 0.00%
ALRN -1.60%
ALT 11.39%
ALVR 4.92%
ALXN 0.00%
ALXO -0.15%
ALZN -7.26%
AMRN 2.72%
AMTI -3.13%
ANAB 0.21%
ANEB -1.49%
ANGN 0.00%
ANIX -0.79%
ANL 0.29%
ANNX -4.22%
ANPC -3.15%
APGE 2.63%
APGN 8.48%
APGNW 30.65%
APLM 9.95%
APLS 0.92%
APLT 1.76%
APM 1.73%
APOP 0.38%
APRE 3.24%
APTO -2.37%
APTX 3.17%
APVO 1.15%
ARAV -13.39%
ARCT -0.44%
ARDS 2.49%
ARDX 1.46%
ARGX 11.69%
ARNA 0.00%
ARPO -0.90%
ARQT 4.59%
ARTL -2.71%
ARTLW 0.00%
ARVN -0.99%
ARWR 6.82%
ASLN -2.99%
ASMB 0.38%
ASND 1.20%
ATAI 4.48%
ATHA 1.28%
ATHE 2.27%
ATHX -33.50%
ATNF 2.05%
ATOS -5.31%
ATRA 0.67%
ATXI 9.52%
ATXS -2.65%
AUPH 2.35%
AURA -1.25%
AUTL -2.87%
AVBP -0.78%
AVEO 0.00%
AVIR 1.45%
AVRO -1.41%
AVTE -3.85%
AVTX 2.99%
AVXL 3.19%
AXLA 0.00%
AXSM 2.76%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO -15.94%
BCAB 3.31%
BCDA -5.67%
BCDAW -39.75%
BCEL 0.00%
BCLI 2.70%
BCRX -2.34%
BCTX -7.44%
BCTXW -18.26%
BCYC 0.10%
BDRX -15.63%
BDTX 0.83%
BEAM 8.24%
BFRA -2.91%
BGNE 1.95%
BIOR 1.50%
BIVI 0.96%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX 3.39%
BLTE 0.27%
BLU 0.03%
BLUE 13.45%
BMEA 5.51%
BMRN 1.62%
BNOX 2.99%
BNTC 4.80%
BNTX 2.33%
BOLD 13.42%
BOLT -1.45%
BPMC 1.79%
BPTH 0.88%
BPTS -13.47%
BRNS 0.00%
BRTX 1.72%
BTAI 4.39%
BTTX 0.00%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI -1.78%
CABA -1.53%
CADL 1.82%
CALA 0.00%
CALC -1.87%
CALT 1.83%
CAPR 1.91%
CARA 22.71%
CARM 9.80%
CASI 7.65%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -4.40%
CCCC 11.08%
CCXI 0.00%
CDAK 0.00%
CDIO -0.17%
CDIOW 36.86%
CDMO -4.38%
CDMOP 0.04%
CDT -7.05%
CDTTW -23.91%
CDTX -2.84%
CDXC -6.59%
CDXS 2.04%
CELC 4.58%
CELU 0.66%
CELUW 11.18%
CERC -1.68%
CERE -0.55%
CERO 2.09%
CEROW -22.90%
CFRX -27.95%
CGEM -0.34%
CGEN -5.08%
CGON 1.50%
CGTX -2.63%
CHMA -6.00%
CHRS -2.40%
CINC 0.00%
CING 4.73%
CINGW 73.79%
CKPT 15.56%
CLBS -16.75%
CLDX 2.55%
CLGN 6.22%
CLLS 1.06%
CLNN -3.46%
CLNNW -33.25%
CLRB 0.00%
CLSD 0.00%
CLSN -0.68%
CLVS 0.00%
CMMB 8.57%
CMND -7.59%
CMPI 0.00%
CMPX 0.91%
CMRA 0.00%
CMRAW 33.33%
CMRX 1.85%
CNCE 0.00%
CNSP 12.63%
CNST 0.00%
CNTA -2.31%
CNTB -6.25%
CNTX 0.93%
COCP -1.88%
COEPW 0.00%
COGT 1.14%
CORT 1.83%
COYA -2.48%
CPRX -1.28%
CRBP 2.42%
CRBU 8.72%
CRDF -3.67%
CRGX 4.50%
CRIS 3.02%
CRNX 0.18%
CRSP 3.02%
CRTX 2.63%
CRVO 0.40%
CRVS 2.81%
CSBR -1.20%
CTCX -7.84%
CTIC 0.06%
CTMX 3.10%
CTNM 3.23%
CTXR 4.68%
CUE 8.89%
CVAC 6.44%
CVKD 6.24%
CWBR 0.00%
CYAD -12.96%
CYCC -5.01%
CYCCP 4.03%
CYCN 6.69%
CYT -2.27%
CYTK 0.71%
CYTO 2.61%
DARE 1.96%
DAWN -1.10%
DBTX -0.81%
DBVT -1.80%
DFFN 10.28%
DICE 0.06%
DMAC 2.78%
DNLI 1.24%
DNTH -0.04%
DOMH -2.63%
DRMA 12.50%
DRMAW -1.25%
DRNA 0.00%
DRTS 1.62%
DRTSW 0.00%
DRUG -3.77%
DSGN -0.59%
DTIL 0.85%
DYAI -9.66%
EARS -1.77%
EDIT -0.59%
EDSA -0.11%
EFTR -75.81%
EFTRW -96.33%
EIGR -9.21%
ELAB 0.86%
ELDN -4.40%
ELEV -4.30%
ELOX 0.00%
ELTX 6.89%
ELVN 1.87%
ELYM -8.69%
ENGN -9.67%
ENGNW -7.87%
ENLV 3.68%
ENOB 1.79%
ENSC 4.98%
ENTA 2.43%
ENTO -2.13%
ENTX 1.98%
ENVB 9.19%
EPIX -1.02%
EPRX 0.57%
EPZM 0.00%
EQ 2.52%
EQRX -2.09%
EQRXW 0.00%
ERAS 2.37%
ERNA -4.64%
ERYP 1.30%
ESLA -0.50%
ESLAW 0.00%
ETNB -0.82%
ETON -0.60%
ETTX 0.00%
EVAX -5.28%
EVGN -2.18%
EVLO 0.00%
EWTX -1.99%
EXAI -2.78%
EXEL 0.54%
EYEG 0.11%
EYEN 2.28%
EYPT 0.59%
FATE 2.13%
FBIO -3.95%
FBIOP 0.59%
FBLG 5.49%
FBRX 0.27%
FDMT 1.35%
FENC -1.09%
FGEN 6.19%
FHTX 0.38%
FIXX 0.77%
FMTX 0.00%
FNCH -6.77%
FOLD -0.89%
FREQ 4.76%
FRLN 0.15%
FRTX -4.51%
FSTX 0.00%
FTRE -0.65%
FULC -5.09%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -8.97%
GANX 0.00%
GBIO 1.45%
GBT 0.01%
GDTC 5.61%
GERN -1.29%
GHRS 0.42%
GLMD -1.83%
GLPG 1.67%
GLSI -4.73%
GLTO 5.51%
GLUE 4.96%
GLYC 3.61%
GMAB -0.81%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT 1.29%
GNLX 10.68%
GNPX 0.00%
GNTA 7.74%
GOSS 27.09%
GOVX 30.04%
GOVXW 49.24%
GPCR -4.15%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS 4.76%
GRTX 40.48%
GTHX -10.48%
GUTS 5.77%
GXGXW 41.67%
GYRE -3.28%
HALO 0.99%
HARP 0.09%
HCWB 10.69%
HEPA 5.42%
HGEN -84.62%
HILS 5.66%
HLVX 2.75%
HOOK -1.07%
HOTH 0.67%
HOWL -9.38%
HRMY -0.10%
HRTX -1.55%
HSTO 0.00%
HUMA -1.35%
HUMAW 5.19%
IBRX 1.10%
ICCC -0.22%
ICPT 0.21%
ICU 10.12%
ICUCW 14.68%
ICVX -0.91%
IDRA -23.04%
IDYA 0.03%
IFRX 8.44%
IGMS 0.00%
IKNA -2.33%
IKT -5.00%
IMAB 2.38%
IMCR -0.28%
IMGN 0.02%
IMGO 0.00%
IMMP -2.92%
IMMX 11.76%
IMNM -4.02%
IMNN -4.46%
IMPL -27.27%
IMRA 15.96%
IMRN 12.11%
IMRX 4.20%
IMTX -1.37%
IMTXW -14.50%
IMUX -0.90%
IMV 0.00%
IMVT 0.18%
INAB -0.84%
INBX 2.18%
INCY 0.84%
INDP -1.33%
INFI -52.38%
INKT -1.62%
INM 9.72%
INMB 1.62%
INO -1.61%
INSM 0.65%
INTS 4.74%
INVA 0.63%
INZY 0.67%
IOBT 0.00%
IONS 6.81%
IOVA 1.87%
IPA -1.92%
IPHA -5.16%
IPSC -6.29%
IRON 1.81%
ISEE 0.38%
ITOS 0.61%
ITRM -5.65%
IVA -0.71%
IVVD 2.42%
JAGX -3.32%
JANX 5.52%
JAZZ 1.72%
JNCE 0.00%
JSPR 1.72%
JSPRW 4.71%
JUNS 0.00%
JUNSW 0.00%
KA 13.13%
KALV -0.17%
KDNY 0.22%
KMPH -0.34%
KNSA 1.40%
KNTE -0.38%
KOD 3.41%
KPRX 9.68%
KPTI 12.76%
KRBP -0.40%
KRON -6.48%
KROS 0.09%
KRRO -0.76%
KRTX 0.03%
KRYS 1.97%
KTRA 6.15%
KTTA 4.85%
KTTAW -5.17%
KURA 0.67%
KYMR -1.69%
KYTX 2.07%
KZIA -15.51%
KZR 1.12%
LABP 0.57%
LBPH 0.05%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.13%
LENZ -1.52%
LEXX -1.49%
LEXXW -0.19%
LGND 0.72%
LGNDV 0.00%
LGVN -12.73%
LIAN -8.28%
LIFE 2.70%
LIPO 10.88%
LIXT -1.57%
LIXTW 0.00%
LJPC -0.32%
LMNL 0.12%
LOGC 1.27%
LPCN 3.56%
LPTX -2.08%
LQDA 3.28%
LRMR -10.33%
LSTA -3.26%
LTRN -5.78%
LUMO 1.79%
LVTX 0.27%
LXEO 4.94%
LXRX -2.16%
LYEL 3.41%
LYRA -2.78%
MACK 0.10%
MBIO 2.70%
MBRX -3.48%
MCRB -2.19%
MDGL 2.00%
MDNA -13.16%
MDWD 7.88%
MDXG -1.02%
MEIP -2.80%
MESO -3.28%
MGNX 2.97%
MGTA -7.74%
MGTX -3.18%
MGX 0.56%
MIRM 8.74%
MIRO 0.59%
MIST 0.72%
MITO 0.00%
MLEC -5.36%
MLECW 90.24%
MLND -5.36%
MLTX 0.73%
MLYS 4.90%
MNKD 6.26%
MNMD 0.27%
MNOV 0.00%
MNPR 15.76%
MOLN -25.10%
MOR -0.11%
MORF 10.26%
MREO -5.53%
MRKR 9.03%
MRNA 2.70%
MRNS 3.01%
MRSN 3.76%
MRTX -0.17%
MRUS 3.77%
MRVI -2.35%
MTCR -1.29%
MTEM -4.59%
MTP -18.50%
MURA -0.62%
MYMD -4.12%
NAMS 8.93%
NAMSW 26.87%
NAUT -8.57%
NBRV 0.71%
NBSE -1.56%
NBTX 4.81%
NCNA -0.34%
NERV -5.52%
NEXI -2.44%
NGM -1.28%
NGNE 2.39%
NKGN 0.00%
NKGNW 8.00%
NKTR 0.86%
NKTX 1.82%
NLSP -5.16%
NLSPW 28.30%
NMRA 0.00%
NMTR -42.97%
NOVN -24.84%
NRBO 0.49%
NRIX -1.27%
NRSN -3.99%
NRSNW 0.00%
NRXP 0.75%
NRXPW 0.00%
NRXS -0.78%
NTBL 0.36%
NTEC -12.45%
NTHI 0.00%
NTLA 3.22%
NTRBW 0.00%
NUVL 1.72%
NVAX 0.14%
NVCT 2.13%
NVIV -34.28%
NXTC 3.70%
NYMX -0.05%
OABI 1.75%
OABIW -3.65%
OBIO 9.02%
OBSV 0.00%
OCEA 7.75%
OCGN -5.26%
OCS 1.37%
OCUL 4.48%
OCUP 1.27%
ODT -4.27%
OKYO -1.63%
OLMA 2.15%
OMER 2.90%
OMGA -0.41%
ONCO -6.85%
ONCR -3.08%
ONCS 31.87%
ONCT -1.85%
ONCY 0.00%
ONTX -0.47%
ONVO -2.28%
OPNT 0.00%
OPT -4.93%
ORGS -3.25%
ORIC -1.11%
ORMP -3.04%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -2.62%
OVID 1.28%
OYST 0.00%
PALI -3.95%
PASG 0.00%
PBLA -4.76%
PBM -4.74%
PBYI -2.34%
PCSA 0.51%
PCVX 1.12%
PDSB 8.33%
PEPG 4.57%
PGEN 4.55%
PHAR 13.76%
PHAS 0.00%
PHAT -2.26%
PHIO 3.65%
PHIOW 36.47%
PHVS -4.62%
PHXM -5.20%
PIRS -5.56%
PKBO 0.00%
PKBOW 999 900.00%
PLRX 3.28%
PLUR -0.44%
PMN -0.63%
PMVP 4.64%
PNT 0.16%
PPBT 5.78%
PRAX -2.61%
PRDS 0.93%
PRLD 2.88%
PROG -3.47%
PROK -7.60%
PRQR -3.51%
PRTA 0.56%
PRTC -6.90%
PRTG -0.04%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -11.11%
PSTX -1.08%
PTCT -2.05%
PTE -0.82%
PTGX -0.78%
PTIXW -5.10%
PULM -2.53%
PXMD 0.00%
PYPD -1.97%
PYXS -5.34%
QLGN -8.10%
QNCX 0.71%
QNRX 1.44%
QSI 0.84%
QSIAW 1.20%
QTTB -0.71%
QURE -1.09%
RAIN -1.63%
RANI -0.96%
RAPT 3.18%
RARE -0.45%
RCKT 7.03%
REGN 1.02%
RENB 1.27%
REPL 3.06%
RETA 0.02%
REUN -0.89%
REVB 13.74%
REVBU 3.46%
REVBW 50.29%
RGLS -18.33%
RGNX 6.41%
RIGL 0.65%
RLAY -0.58%
RLMD -0.99%
RLYB 5.48%
RNA 1.69%
RNAC 1.05%
RNAZ 5.27%
RNXT 4.09%
ROIV 2.06%
ROIVW 4.56%
RPHM 0.00%
RPRX 0.74%
RPTX 0.28%
RUBY 2.70%
RVLP -32.05%
RVMD 0.76%
RVMDW 17.51%
RVNC -3.38%
RVPH 2.40%
RVPHW 1.92%
RXDX 0.09%
RXRX 5.54%
RYTM 1.58%
RYZB 0.02%
RZLT 7.85%
SABS 4.23%
SABSW -35.81%
SAGE 3.86%
SANA 0.54%
SAVA -1.10%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI -6.67%
SCPH 1.24%
SCPS 0.00%
SEEL -2.49%
SEER 1.76%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO 5.62%
SGMT 6.87%
SGTX -2.56%
SIOX 22.63%
SLDB 2.48%
SLGL 0.59%
SLN 3.61%
SLNO -2.60%
SLRX -3.97%
SLS -0.82%
SMMT 0.88%
SNDX -1.25%
SNGX -2.31%
SNPX 5.67%
SONN -6.53%
SPPI -0.49%
SPRB 5.39%
SPRC -2.42%
SPRO -2.92%
SRNE 15.79%
SRPT 1.95%
SRRA 0.00%
SRRK -0.47%
SRZN 5.26%
STAB 0.00%
STOK 0.70%
STRO -4.95%
STSA 0.00%
STTK -9.50%
SURF -0.93%
SVRA -5.67%
SWTX -0.17%
SYBX 2.01%
SYRS 4.12%
TALS -0.73%
TARA -1.33%
TARS 1.36%
TBPH 0.23%
TCBP -8.11%
TCDA 0.00%
TCON -1.60%
TCRR 0.00%
TCRT -3.84%
TCRX 2.92%
TECH 1.13%
TENX 9.03%
TERN 4.01%
TFFP 9.20%
TGTX 4.31%
THRX 0.12%
TIL -3.68%
TLC 0.00%
TLSA 14.49%
TNGX 0.50%
TNXP -8.46%
TNYA -0.96%
TPST 2.96%
TRDA -4.11%
TRVI -2.22%
TRVN -13.99%
TSHA -10.14%
TSVT 3.76%
TTNP -14.84%
TVTX 6.57%
TYRA 0.35%
UBX 0.36%
UNCY 7.44%
URGN 5.81%
UTHR 0.92%
VACC 11.36%
VALN 12.99%
VAXX -10.53%
VBIV 3.44%
VBLT -8.77%
VCEL 2.64%
VCNX -0.49%
VCYT 1.77%
VERA -2.79%
VERU 9.04%
VERV -0.19%
VIGL 0.52%
VINC -1.38%
VIR 0.22%
VIRI -1.85%
VIRX -5.63%
VKTX -1.18%
VLON -13.04%
VNDA -2.29%
VOR 4.20%
VRCA -4.56%
VRDN 5.09%
VRNA 4.60%
VRPX -4.95%
VRTX 1.33%
VSTM -1.90%
VTGN -3.58%
VTVT 0.00%
VTYX -0.80%
VXRT 5.82%
VYGR -0.43%
VYNE -4.95%
VYNT 7.78%
WINT 7.90%
WVE -0.76%
XBIO -5.83%
XBIT -12.02%
XCUR -3.35%
XENE -0.21%
XERS 0.00%
XFOR 0.00%
XLO 2.47%
XLRN 0.00%
XNCR 1.46%
XOMA 5.64%
XOMAO -0.20%
XOMAP -0.76%
XRTX -2.38%
YMAB 0.83%
ZGNX 0.00%
ZIOP -0.88%
ZLAB 0.97%
ZNTL -3.16%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-18 Bunn Paul A. Buy 12 500 Stock Option (right to buy)
2024-06-18 Bunn Paul A. Buy 8 333 Common Stock
2024-06-18 Rowinsky Eric K Buy 12 500 Stock Option (right to buy)
2024-06-18 Rowinsky Eric K Buy 8 333 Common Stock
2024-06-18 Kapur Anil Buy 12 500 Stock Option (right to buy)
INSIDER POWER
49.14
Last 100 transactions
Buy: 638 383 | Sell: 236 292
Korelacja (AI algo v.1.1b): Undervalued: 0.05% $3.10 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Wolumen Korelacja

Długi: 0.27 (neutral)
Krótki: -0.10 (neutral)
Signal:(51.943) Neutral

Verastem Inc Korelacja

10 Najbardziej pozytywne korelacje
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Verastem Inc Korelacja - Waluta/Towar

The country flag 0.43
( neutral )
The country flag 0.44
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.46
( neutral )

Verastem Inc Finanse

Annual 2023
Przychody: $0
Zysk brutto: $-62 000.00 (0.00 %)
EPS: $-3.96
FY 2023
Przychody: $0
Zysk brutto: $-62 000.00 (0.00 %)
EPS: $-3.96
FY 2022
Przychody: $2.60M
Zysk brutto: $2.48M (95.45 %)
EPS: $-4.58
FY 2021
Przychody: $2.05M
Zysk brutto: $2.05M (100.00 %)
EPS: $-0.464

Financial Reports:

No articles found.

Verastem Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Verastem Inc

Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages in developing RAMP 201, an adaptive two-part multicenter, parallel cohort, randomized open label trial to evaluate the efficacy and safety of VS-6766 and in combination with defactinib, an oral small molecule inhibitor of focal adhesion kinase (FAK) in patients with recurrent low grade serous ovarian cancer; and RAMP 202, which is in Phase 2 trial to evaluate the safety of VS-6766 in combination with defactinib in patients with KRAS and BRAF mutant non-small cell lung cancer following treatment with a platinum-based regimen and immune checkpoint inhibitor. Verastem, Inc. has license agreements with Chugai Pharmaceutical Co., Ltd. for the development, commercialization, and manufacture of products containing VS-6766; and Pfizer Inc. to research, develop, manufacture, and commercialize products containing Pfizer's inhibitors of FAK for therapeutic, diagnostic and prophylactic uses in humans. In addition, it has clinical collaboration agreement with Amgen, Inc. to evaluate the combination of VS-6766 with Amgen's KRAS-G12C inhibitor LUMAKRASTM which in Phase 1/2 trial entitled RAMP 203. The company was incorporated in 2010 and is headquartered in Needham, Massachusetts.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej

Total Execution Time: 1.7550001144409 seconds
Number of API calls: 3
Number of DB calls: 9